scroll to top
0

EBSCO Auth Banner

Let's find your institution. Click here.

Advanced Search Results For "bladder cancer"

1 - 10 of 45,456 results for
 "bladder cancer"
Results per page:

Dynamic changes of quality of life in muscle-invasive bladder cancer survivors.

Publication Type: Academic Journal

Source(s): BMC urology [BMC Urol] 2022 Aug 20; Vol. 22 (1), pp. 126. Date of Electronic Publication: 2022 Aug 20.

Authors:

Abstract: Background: To explore the dynamic changes and effects of radical cystectomy on quality of life in muscle-invasive bladder cancer survivors.Methods: Patients with muscle-invasive bladder cancer were randomly recruited in this study. We used the World H...

View details

Identification and validation of methylated PENK gene for early detection of bladder cancer using urine DNA.

Publication Type: Academic Journal

Source(s): BMC cancer [BMC Cancer] 2022 Nov 19; Vol. 22 (1), pp. 1195. Date of Electronic Publication: 2022 Nov 19.

Authors:

Abstract: Background: Early detection of bladder cancer (BCa) offers patients a favorable outcome and avoids the need for cystectomy. Development of an accurate and sensitive noninvasive BCa diagnostic test is imperative. DNA methylation is an early epigenetic e...

View details

The argument against screening for bladder cancer in neuro-urological patients.

Publication Type: Academic Journal

Source(s): World journal of urology [World J Urol] 2022 Aug; Vol. 40 (8), pp. 1915-1919. Date of Electronic Publication: 2021 Aug 19.

Authors:

Abstract: Purpose: The objective of this article was to present the case against screening people with neuro-urological disease for bladder cancer.Methods: Literature around bladder cancer in neuro-urological patients (primarily spinal cord injured patients [SCI...

View details

Development of a CAFs-related gene signature to predict survival and drug response in bladder cancer.

Publication Type: Academic Journal

Source(s): Human cell [Hum Cell] 2022 Mar; Vol. 35 (2), pp. 649-664. Date of Electronic Publication: 2022 Jan 19.

Authors:

Abstract: As one of important components of tumor microenvironment, CAFs (cancer-associated fibroblasts) play a vital role in the development and metastasis of bladder cancer. The present study aimed to develop a CAFs-related gene signature to predict the progno...

View details

Investigation of the relationship between MTRR A66G, MTR A2756G gene variations and cell anomalies in early diagnosis and progression of bladder cancer.

Publication Type: Academic Journal

Source(s): Molecular biology reports [Mol Biol Rep] 2022 Aug; Vol. 49 (8), pp. 7719-7729. Date of Electronic Publication: 2022 Jun 17.

Abstract: Background: The aim of this study is to investigate the relationship between MTRR A66G, MTRA2756G gene variations and cell anomalies in the early diagnosis and progression of bladder cancer.Methods: PCR and RFLP methods were used to determine the genot...

View details

Screening of MicroRNA Biomarkers Related to the Progression of Bladder Cancer.

Publication Type: Academic Journal

Source(s): Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2022 Aug; Vol. 37 (6), pp. 424-434. Date of Electronic Publication: 2021 Mar 03.

Authors:

Abstract: Objective: This study aimed to identify the novel microRNAs (miRNAs) for early diagnosis of bladder cancer. Materials and Methods: Differentially expressed miRNAs between early and advanced bladder cancer were identified b...

View details

Molecular and Pharmacological Bladder Cancer Therapy Screening: Discovery of Clofarabine as a Highly Active Compound.

Publication Type: Academic Journal

Source(s): European urology [Eur Urol] 2022 Sep; Vol. 82 (3), pp. 261-270. Date of Electronic Publication: 2022 Apr 04.

Abstract: Background: The heterogeneity of bladder cancers (BCs) is a major challenge for the development of novel therapies. However, given the high rates of recurrence and/or treatment failure, the identification of effective therapeutic strategies is an urgen...

View details

High-throughput screening identifies stevioside as a potent agent to induce apoptosis in bladder cancer cells.

Publication Type: Academic Journal

Source(s): Biochemical pharmacology [Biochem Pharmacol] 2022 Sep; Vol. 203, pp. 115166. Date of Electronic Publication: 2022 Jul 09.

Authors:

Abstract: Background: Bladder cancer (BC) is a global health issue that lacks effective treatment strategies. Growing evidence suggests that various natural products possess anti-tumour effects. This study aims to identify a novel agent that can be used in the t...

View details

Diagnostic panel of serum miR-125b-5p, miR-182-5p, and miR-200c-3p as non-invasive biomarkers for urothelial bladder cancer.

Publication Type: Academic Journal

Source(s): Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2022 May; Vol. 24 (5), pp. 909-918. Date of Electronic Publication: 2022 Jan 14.

Authors:

Abstract: Purpose: This study aimed to identify a diagnostic panel of serum microRNAs (miRNAs) for the early detection of bladder cancer (BC).Methods: Serum samples were collected from 112 BC patients and 112 normal controls (NCs). A three-stage selection was co...

View details

Apoptotic and anti-angiogenic effects of propolis against human bladder cancer: molecular docking and in vitro screening.

Publication Type: Academic Journal

Source(s): Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals [Biomarkers] 2022 Mar; Vol. 27 (2), pp. 138-150. Date of Electronic Publication: 2022 Jan 03.

Abstract: Introduction: Bladder cancer is still of unknown initiation and progression, it is difficult to treat the patient once bladder cancer have a distant metastasis.Materials and Methods: In the present study, propolis extract was evaluated against bladder ...

View details
sponsored